Published Research

Our Protocols
Psychedelic Therapy
Published Research

Published Research

Explore our growing list of published research on psychedelic-assisted therapy featured in medical journals and publications.

Psilocybin‐assisted group therapy in patients diagnosed with cancer and depression

Agrawal M., Richards W., Beaussant Y., et al. “Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder.” Cancer, July 2023.

Journal of Palliative Medicine cover

Direct observation measure of therapeutic connection in psilocybin-assisted therapy

Gramling R., Bennett E., Curtis K., et al. “Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.” Journal of Palliative Medicine, August 2023.

Research review

Group psychedelic therapy: empirical estimates of cost-savings and improved access

Marseille E., Stauffer C., Agrawal M., et al. “Group psychedelic therapy: empirical estimates of cost-savings and improved access.” Front. Psychiatry, Dec. 2023.

Acceptability of psilocybin-assisted group therapy in patients with cancer and MDD

Beaussant Y., Tarbi E., Nigam K., et al. “Acceptability of psilocybin-assisted group therapy in patients with cancer and MDD.” Cancer, Dec 2023.

Man showing grief

The potential for psychedelics to treat Prolonged Grief Disorder

Ehrenkranz R., Agrawal M., Penberthy J., Yaden., D. "Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder." International Review of Psychiatry, May 2024.

Psychedelic Medicine cover

Adverse events should not be surprising in psychedelic research

Ehrenkranz R., Agrawal M., Nayak S., Yaden., D. "Adverse Events Should Not Be Surprising in Psychedelic Research." Psychedelic Medicine, September 2024.

The epidemiology of psychedelic use among U. S. military veterans

Davis A., Bates M., Koffman R., et al. “The Epidemiology of Psychedelic Use Among United States Military Veterans.” Journal of Psychoactive Drugs, Sep 2024.

Long-term benefits of single-dose psilocybin in depressed cancer patients

Agrawal M., Emanuel E., Jenkins B., et al. "Long-term Benefits of Single-Dose Psilocybin in Depressed Cancer Patients." Cancer, June 2025.

Psychotherapy for psilocybin-assisted therapy among patients with advanced cancer and major depression

Rosa, W.E., Napolitano, S., McAndrew, N.S., Jenkins, B., et al. "Meaning-centered psychotherapy for psilocybin-assisted therapy among patients with advanced cancer and major depression: Rationale and preliminary evaluation of MCP-PSIL." Psychedelic Medicine, August 2025.

person typing on laptop with stethoscope nearby

To have the encounter with our own finiteness in that existential way

Tarbi, E. C., Miner, S. A., Nigam, K., et al. “To have the encounter with our own finiteness in that existential way”: Descriptions of existential experience in patients with cancer and major depression participating in psilocybin-assisted group therapy. Psychedelic Medicine, August 2025. #2